A Randomized, Double-Blind, Comparative Trial of the Safety and Efficacy of Famotidine vs Placebo for the Treatment of Non-Hospitalized Symptomatic Adults With COVID-19
January 26, 2021 | Community/Outpatient Based |
80mg x 3 daily for a maximum of 14 days, or until hospital admission
Please check the captcha to verify you are not a robot.
IMPORTANT: To protect your privacy, your subscription will only be confirmed once you click on the confirmation link in the email just sent to you. If the email is not in your inbox, check your junk/spam folder.
Something went wrong. Please check your entries and try again.